413 related articles for article (PubMed ID: 25203323)
1. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
[TBL] [Abstract][Full Text] [Related]
2. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
3. RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.
Yong H; Zhao W; Zhou X; Liu Z; Tang Q; Shi H; Cheng R; Zhang X; Qiu Z; Zhu J; Feng Z
Med Sci Monit; 2019 May; 25():4025-4034. PubMed ID: 31145716
[TBL] [Abstract][Full Text] [Related]
4. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
[TBL] [Abstract][Full Text] [Related]
5. RBM4-regulated alternative splicing suppresses tumorigenesis.
Cancer Discov; 2014 Nov; 4(11):1253. PubMed ID: 25367940
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
7. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
8. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
Lin JC; Lin CY; Tarn WY; Li FY
RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
10. Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD.
Leu S; Lin YM; Wu CH; Ouyang P
J Cell Sci; 2012 Jul; 125(Pt 13):3164-72. PubMed ID: 22454513
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.
Markus MA; Yang YH; Morris BJ
Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347
[TBL] [Abstract][Full Text] [Related]
12. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
13. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract][Full Text] [Related]
14. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
15. Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
Ji L; Ni T; Shen Y; Xue Q; Liu Y; Chen B; Cui X; Lv L; Yu X; Cui Y; Lu X; Chen J; Mao G; Wang Y
J Mol Histol; 2014 Oct; 45(5):573-82. PubMed ID: 24952301
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
17. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
[TBL] [Abstract][Full Text] [Related]
18. The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival.
Naro C; Barbagallo F; Chieffi P; Bourgeois CF; Paronetto MP; Sette C
Nucleic Acids Res; 2014 Mar; 42(5):3218-27. PubMed ID: 24369428
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
Shultz JC; Goehe RW; Wijesinghe DS; Murudkar C; Hawkins AJ; Shay JW; Minna JD; Chalfant CE
Cancer Res; 2010 Nov; 70(22):9185-96. PubMed ID: 21045158
[TBL] [Abstract][Full Text] [Related]
20. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.
Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC
Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
